Company / Current Assets per Share
Arcturus Therapeutics Holdings Inc. Current Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$8.94
FY2025
5-year range
$8.94 / $15.29
FY2021-FY2025
Trend
-21.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 3 consecutive years, from $15.29 in FY2022 to $8.94 in FY2025.
Based on SEC 10-K filings.
8.94 in FY2025 with a 5-year CAGR of -22.0%.
Declined from $14.56 to $8.94 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -16.4%
- 5-Year CAGR
- -22.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcturus Therapeutics Holdings Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 21.6% year-over-year.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.94 | -21.6% |
| FY2024 | $11.41 | -21.7% |
| FY2023 | $14.56 | -4.8% |
| FY2022 | $15.29 | +5.7% |
| FY2021 | $14.47 | -53.2% |
| FY2020 | $30.90 | +345.9% |
| FY2019 | $6.93 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026